SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-018941
Filing Date
2016-05-10
Accepted
2016-05-10 16:11:22
Documents
57
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q arwr-10q_20160331.htm 10-Q 1678350
2 EX-31.1 arwr-ex311_8.htm EX-31.1 10923
3 EX-31.2 arwr-ex312_9.htm EX-31.2 11417
4 EX-32.1 arwr-ex321_10.htm EX-32.1 6766
5 EX-32.2 arwr-ex322_6.htm EX-32.2 7056
  Complete submission text file 0001564590-16-018941.txt   5248629

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT arwr-20160331.xml EX-101.INS 838689
7 XBRL TAXONOMY EXTENSION SCHEMA arwr-20160331.xsd EX-101.SCH 41739
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arwr-20160331_cal.xml EX-101.CAL 52328
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arwr-20160331_def.xml EX-101.DEF 138244
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE arwr-20160331_lab.xml EX-101.LAB 373628
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arwr-20160331_pre.xml EX-101.PRE 284086
Mailing Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101
Business Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101 626-304-3400
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

IRS No.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-21898 | Film No.: 161635880
SIC: 8731 Services-Commercial Physical & Biological Research